DİLEK BENK ŞİLFELER, ARİF GÜNGÖREN, Serdar Kenan DOLAPÇIOĞLU, Ebru TURHAN, Sibel HAKVERDİ, Duygu ERDEM, Ali Ulvi HAKVERDİ, Ali BALOĞLU

Overlerde Neoplastik ve Non-neoplastik Kistik Lezyonların Değerlendirilmesi

Amaç: Opere edilmiş over kist olgularında Neoplastik ve non- neoplastik lezyonların oranlarının belirlenmesini amaçladık. Gereç ve yöntemler: Ocak 2005 ile Nisan 2011 tarihleri arasında eleHastanemiz Kadın Hastalıkları ve Doğum servisinde2005 -2010 tarihleri arasında overde kistik kitle ön tanısıyla opere olmuş 126 hastanın dosyaları retrospektif olarak incelendi. Bulgular: Overyan kitleler içerisinde 41 hastada non- neoplastik kistler(%32,5) ve 85 hastada neoplastik tümorler (%67,4) izlenmiştir. Neoplastik tümörler içerisinde 74 benign (%58,7), 3 borderline(%2,4) ve 8 malign tümör (%6,3) izlenmiştir. Tüm malign over tümörlü olgular elektif şartlarda ve laparatomi ile opere edilmişlerdir. Ortalama görülme yaşı 46±13 iken, kist çapı ise 18±7.9 cm olarak ölçülmüştür. % 75 oranında malignite sağ over kaynaklıdır. Ortalama Ca-125 değeri 1.420 ± 2.079 idi. Tartışma: Over kaynaklı kistik kitlelerin % 91i patolojik olarak bening olarak saptanmıştır. Her bir olgu ultrasonografi, yaş, tümör belirteçleri ile klinik olarak değerlendirilmeli ve mümkünse elektif şartlarda opere edilmelidir. Bening olduğu düşünülen hastalarda öncelikli olarak laparoskopi tercih edilmeli ve minimal invaziv yaklaşımla over dokusunun korunmasına özen gösterilmelidir.

Classification of Neoplastic and Non-neoplastic Cystic Lesions in Ovaries

Classification of Neoplastic and Non-neoplastic Cystic Lesions in Ovaries Purpose: Determination of the rates of neoplastic and non-neoplastic lesions in ovary cyst cases having been operated. Material and methods: Files of 126 patients being operated with pre-diagnosis of cystic mass in ovary in obstetrics and gynecology service of our hospital between 2005 and 2010 were inspected retrospectively. Findings: TNon-neoplastic cysts in 41 patients (32,5%) and neoplastic tumors in 85 patients (67,4%) were observed out of ovarian masses. 74 benign (58,7%), 3 borderline(2,4%) and 8 malign tumors (6,3%) were observed in neoplastic tumors. All malign ovary tumors cases were operated in elective conditions using laparoscopy. While the average age of patients having these problems was 46±13, average cyst diameter was measured as 18±7.9 cm. 75% of malignancy was resulted from right ovary. The average Ca-125 value was 1420 ± 2079. Discussion: 91 % of cystic masses resulting from ovary were detected as benign in histopathological inspection. Each case has to be evaluated considering ultrasonography, age, tumor determinant and operated in elective conditions if possible. Laparoscopy has to be preferred first of all for the patients that were supposed to suffer from benign and protection of ovary tissue has to be taken care of with minimal invasive approach.

PDF

___

1) Imaoka I, Wada A, Kaji Y, Hayashi T, Hayashi M, Matsuo M, Sugimura K. Developing an MR Imaging Strategy for Diagnosis of Ovarian Masses. Radiographics, 2006;26(5):1431-48.
2) Sutton CL, McKinney CD, Jones JE, Gay SB. Ovarian Masses Revisited:Radiologic and Pathologic Correlation. Radiographics. 1992;12(5):853-77.
3) Akercan F, Cirpan T, Yildiz PS, Ozsener S, Karadadas N, Ulukis M. Approaches To The Dıagnosıs And Treatment Of Benign Adnexial Masses. Ege Tıp Dergisi 2005;44(3):151- 54
4) Guerriero S, Ajossa S, Garau N, Piras B, Paoletti AM, Melis GB.Ultrasonography and color Doppler-based triage for adnexal masses to provide the most appropriate surgical approach. Am J Obstet Gynecol. 2005;192(2):401-6.
5) Timmerman D, Verrelst H, Collins WP, Bourne TH, Vergote I. Re: Mol et al. Distinguishing the benign and malignant adnexial mass: an external validation of prognostic models. Gynecol Oncol 2001;83(1):166-8
6) Morgan A. Adnexial mass evaluation in the emergency department. Emerg Med Clin North Am 2001;19(3):799-816
7) Clement PB. Nonneoplastic lesions of the ovary. In: Kurman RJ, ed. Blausteins pathology of the female genital tract. 5th ed. New York, NY: Springer-Verlag, 2002;675727.
8) Hillard PA. Kadın Genital Traktus Benign Hastalıkları: Semptom ve Bulgular. Berek JS, Adashi EY, Hillard PA(eds). Novak Jinekoloji, 12. Baskı. Cev. Editoru: Erk A. İstanbul: Nobel Tıp Kitabevi, 1998;331-97.
9) Koonings PP, Campbell K, Mishell DR Jr, Grimes DA. Relative frequency of primary ovarian neoplasms: a 10 year review. Obstet Gynecol 1989;74:921-6.
10) Gershenson DM. Clinical management potential tumours of low malignancy. Best Pract Res Clin Obslet Gynaecol 2002;16:513-27.
11) Herbst AL. The epidemiology of ovarian carcinoma and the current status of tumor markers to detect disease. Am J Obstet Gynecol 1994;170:1099-105.
12) Berchuck A, Schildkraut JM, Marks JR, Futreal PA. Managing hereditary ovarian cancer risk. Cancer, 1999;86:2517-24.
13) Horner MJ, Ries LAG, Krapcho M, et al. SEER cancer statistics review, 19752006, National Cancer Institute. SEER Website. http://seer. cancer.gov/csr/1975_2006 Based on November 2008 SEER data submission. Published May 29, 2009. Accessed December 3, 2009
14) Timor-Trish IE, Lerner JP, Monteagudo A, Santos R. Transvaginal ultrasonographic characterization of ovarian masses by means of colorflow-directed Doppler measurements and a morphologic scoring system. Am J Obstet Gynecol 1993;168:90913
15) Lerner JP, Timor-Trish LE, Federman A, Abramovich G. Transvaginal ultrasonographic characterization of ovarian masses with an improved, weighted scoring system. Am J Obstet Gynecol 1994;170:8185
16) Buy JN, Ghossain MA, Hugol D, et al. Characterization of adnexal masses: combination of color Doppler and conventional sonography compared with spectral Doppler analysis alone and conventional sonography alone. AJR 1996;166:38593
17) Wu CC, Lee CN, Chen TM, Lai JI, Hsieh CY, Hwieh FJ. Factors contributing to the accuracy in diagnosing ovarian malignancy by color Doppler ultrasound. Obstet Gynecol 1994;84:6058
18) Predanic M, Vlahos N, Pennisi JA, Moukhtar M, Alee FA. Color and pulsed Doppler sonography, gray-scale imaging, and serum CA 125 in the assessment of adnexal disease. Obstet Gynecol 1996;88:288
19) Dorigo O, Baker VV. Premalignant and Malignant Disorders of the Ovaries and Oviducts, In: DeCherney AH, Nathan L(eds). Current Obstetric Gynecologic Diagnosis treatment, 9th Ed. Los Angeles, California: McGraw-Hill Companies, Inc., 2003;49-64
20) Ayhan A, Basaran M. Epitelyal over kanserleri. In:Guner H (ed), Jinekolojik Onkoloji, 3. Baskı. Ankara: Cagdaş Medikal kitabevi, 2002;14:201-43
21) Arvas M, Göker B. Germ Hücreli Over Hucreli Over Tumorleri. In: Guner H (ed), Jinekolojik Onkoloji, 3. Baskı. Ankara: Çağdaş Medikal Kitabevi, 2002;15:245-55
22) Dilek S, Dede M. Overin germ hücreli tumorleri. In: Cicek MN, Akyurek C, Celik C, Haberal A (eds), Kadın Hastalıkları ve Doğum Bilgisi, Ankara: Güneş Kitabevi Ltd. Şti. 2004;84:945-52
23) Güner H. Overin seks kord stromal tumorleri. In: Cicek MN, Akyurek C, Celik C, Haberal A (eds), Kadın Hastalıkları ve Doğum Bilgisi. Ankara: Gunes Kitabevi Ltd. Şti. 2004;85:953-7
24) Guppy AE, Rustin GJ. CA125 response: can it replace the traditional response criteria in ovarian cancer? Oncologist 2002;7:437-43.
25) Meyer T, Rustin JG. Role of tumour markers in monitoring epithelial ovarian cancer. Br J Cancer 2000;182:1535-8.
26) Norum LF, Erikstein B, Nustad K. Elevated CA-125 in breast cancer A sign of advanced disease. Tumour Biol 2001;22(4),223-8.
27) Kerbrat P, Lhomme C, Fervers B, Guastalla JP, Thomas L, Tournemaine N, et al. Ovarian Cancer. Br J Cancer 2001;84:18-23.
28) Sjovall K, Nilsson B, Einhorn N. The signifance of serum CA125 elevation in malignant and nonmalignant diseases. Gynecol Oncol 2002;85(1):175-8.
29) Pejovic T, Nezhat F. Laparoscopic management of adnexial masses, the opportunities and the risks. Ann N Y Acad Sci 2001;943:255-68
30) Chapron C, Dubuisson JB, Capella-Allouc S. Salpingo-oophorectomy for adnexial masses. Place and results for operative laparoscopy. Eur J Obstet Gynecol Reprod Biol 1997;73(1):43-8
31) Buquet RA, Amato AR, Huang GB, Singla J, Ortiz J, Ortiz OC. Is preoperative selection of patients with cystic adnexial masses essential for laparoscopic treatment? J Am Assoc Gynecol Laparosc 1999;6(4):477-81
32) Ou CS, Liu YH, Zabriskie V, Rowbotham R. Alternate methods for laparoscopic management of adnexial masses greater than 10 cm in diameter. J Laparoendosc Adv Surg Tech A 2001;11(3):125-32
33) Curtin JP. Management of the adnexial mass. Gynecol Oncol 1994;55:42-6
34) Argenta PA, Nezhat F. Approaching the adnexial mass in the new millennium. J Am Assoc Gynecol Laparosc 2000;7(4):455-71
35) Dietrich M, Osmers RG, Grobe G, Zech G, Suren A, Krauss T, Sander H, Fischer G, Kuhn W. Limitations of the evaluation of adnexial masses by its macroscopic aspects, cytology and biopsy. Eur J Obstet Gynecol Reprod Biol 1999;82(1):57-62